We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Three-year results continue to show that Abbott’s Amplatzer Piccolo Occluder, which was approved by the FDA in 2019, is safe and effective in nonsurgically closing a hole in the heart of premature infants. Read More
AposHealth’s Apos biomechanical knee treatment helped most patients suffering from disabling osteoarthritis (OA) to be able to delay knee replacement surgery for 24 months, according to data from an observational study published in the journal Population Health Management. Read More
A group of researchers representing devicemakers, academic institutions and the FDA has published a list of factors device developers should consider when collecting patient preference information (PPI) to help design trials. Read More
Medcura’s injectable biopolymer LifeFoam significantly extended survival time in an animal study, researchers reported in the journal Surgery. Read More
Patients with type 1 diabetes using Medtronic’s MiniMed 780G insulin pump system had reduced blood glucose levels and increased time spent in the target blood sugar range compared to patients given insulin injections, researchers reported in the journal The Lancet Diabetes & Endocrinology. Read More
Nearly 60 percent of patients using Abbott’s Heartmate 3 heart pump are reaching the five-year survival mark, according to results of a postmarket study reported at the 2022 European Society of Cardiology Congress in Barcelona, Spain, Aug. 26-29. Read More
MIT researchers have developed a device that uses artificial intelligence (AI) to detect Parkinson’s disease by monitoring a person’s breathing patterns while they sleep. Read More
Penumbra’s RED reperfusion catheter was effective in removing blood clots in acute eschemic stroke (AIS) patients, according to study data reported at the 2022 World Federation of Interventional and Therapeutic Neuroradiology (WFITN) in Kyoto, Japan, last week. Read More
Bioretec’s ActivaPin bioresorable implant has proven to be an acceptable alternative treatment for pediatric elbow fractures, researchers reported in the journal Medicine.
A new DNA sequencing test that detects extra or missing fetal chromosomes has results comparable to standard clinical tests, is less expensive and can be done at the point of care in one day, according to a study led by researchers at New York’s Columbia University.
When it comes to blood pressure monitoring at home, old-fashioned blood pressure cuffs work just as well as newer, app-based technology, researchers reported in the journal JAMA Internal Medicine. Read More
Researchers in Europe used Abbott’s i-STAT TBI (traumatic brain injury) test to show how two blood-based biomarkers can effectively predict the initial outcome of such injuries. Read More